Publication:
Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet

Thumbnail Image

Date

2014

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The American Society of Tropical Medicine and Hygiene
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Deshpande, Bhushan R., Sowmya R. Rao, Emily S. Jentes, Susan L. Hills, Marc Fischer, Mark D. Gershman, Gary W. Brunette, Edward T. Ryan, and Regina C. LaRocque. 2014. “Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet.” The American Journal of Tropical Medicine and Hygiene 91 (4): 694-698. doi:10.4269/ajtmh.14-0062. http://dx.doi.org/10.4269/ajtmh.14-0062.

Research Data

Abstract

Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

Description

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories